Page 483«..1020..482483484485..490500..»

How stress and the circadian clock affect sleep? – Tech Explorist

Posted: Published on November 28th, 2020

A circadian rhythm is a roughly 24-hour cycle in the physiological processes of living beings. The rhythm monitors the sleeping and feeding patterns of all animals, including human beings. Continue reading →

Posted in Hypothalamus | Comments Off on How stress and the circadian clock affect sleep? – Tech Explorist

Sniff and Squat: The Smell of Exercise Is a Motivator to Work Out – Technology Networks

Posted: Published on November 28th, 2020

Exercise motivation could be linked to certain smells. Credit: Stan Lim, UC Riverside. Read Time: On a near-daily basis, the internet spews out numerous tips and tricks for exercise motivation Continue reading →

Posted in Hypothalamus | Comments Off on Sniff and Squat: The Smell of Exercise Is a Motivator to Work Out – Technology Networks

Calculated Treatment Response Score May Help Choose Between MS Therapies – Neurology Advisor

Posted: Published on November 28th, 2020

A treatment response score consisting of a combination of age, sex, relapses in the previous year, disease duration, and Expanded Disability Status Scale (EDSS) could help determine which patients with multiple sclerosis (MS) would benefit from glatiramer acetate or interferon beta-1 (IFN-1a), according to study results published in Neurology. Continue reading →

Posted in MS Treatment | Comments Off on Calculated Treatment Response Score May Help Choose Between MS Therapies – Neurology Advisor

Clinical observation experience of a pediatric patient with primary progressive multiple sclerosis in the Moscow office for the treatment of children…

Posted: Published on November 28th, 2020

This article was originally published here Zh Nevrol Psikhiatr Im S S Korsakova. 2020;120(10):45-50. Continue reading →

Posted in MS Treatment | Comments Off on Clinical observation experience of a pediatric patient with primary progressive multiple sclerosis in the Moscow office for the treatment of children…

Superoxide dismutase (SOD), advanced oxidation protein products (AOPP), and disease-modifying treatment are related to better relapse recovery after…

Posted: Published on November 28th, 2020

This article was originally published here Neurol Sci. 2020 Nov 26. Continue reading →

Posted in MS Treatment | Comments Off on Superoxide dismutase (SOD), advanced oxidation protein products (AOPP), and disease-modifying treatment are related to better relapse recovery after…

Work Productivity Outcomes Associated with Ocrelizumab Compared with Other Disease-Modifying Therapies for Multiple Sclerosis – DocWire News

Posted: Published on November 28th, 2020

This article was originally published here Neurol Ther. 2020 Nov 26 Continue reading →

Posted in MS Treatment | Comments Off on Work Productivity Outcomes Associated with Ocrelizumab Compared with Other Disease-Modifying Therapies for Multiple Sclerosis – DocWire News

Treatment Start to Full Effect of Immunotherapies for MS – Medscape

Posted: Published on November 28th, 2020

Izanne Roos1,2, Emmanuelle Leray3, Federico Frascoli4, Romain Casey58, J. William L. Brown9, Dana Horakova10, Eva K Continue reading →

Posted in MS Treatment | Comments Off on Treatment Start to Full Effect of Immunotherapies for MS – Medscape

Inflammatory Activity and Treatment Response in Pediatric Compared to Adult Multiple Sclerosis: A Pilot, Retrospective and Observational Study of the…

Posted: Published on November 28th, 2020

This article was originally published here Acta Med Port. 2020 Nov 24. Continue reading →

Posted in MS Treatment | Comments Off on Inflammatory Activity and Treatment Response in Pediatric Compared to Adult Multiple Sclerosis: A Pilot, Retrospective and Observational Study of the…

MediciNova Announces Positive Optical Coherence Tomography Results from the SPRINT-MS Phase 2b Trial of MN-166 (ibudilast) in Progressive MS Published…

Posted: Published on November 28th, 2020

LA JOLLA, Calif., Nov. 25, 2020 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that positive Optical Coherence Tomography (OCT) results from the SPRINT-MS Phase 2b trial of MN-166 (ibudilast) in progressive multiple sclerosis (progressive MS) were published in Multiple Sclerosis Journal. Continue reading →

Posted in MS Treatment | Comments Off on MediciNova Announces Positive Optical Coherence Tomography Results from the SPRINT-MS Phase 2b Trial of MN-166 (ibudilast) in Progressive MS Published…

Informing the Development of a Digital Health Platform Through Universal Points of Care: Qualitative Survey Study – DocWire News

Posted: Published on November 28th, 2020

JMIR Form Res. 2020 Nov 26;4(11):e22756. doi: 10.2196/22756. Continue reading →

Posted in MS Treatment | Comments Off on Informing the Development of a Digital Health Platform Through Universal Points of Care: Qualitative Survey Study – DocWire News

Page 483«..1020..482483484485..490500..»